Webinar replay

Changing the Partner Discovery Game with Connect for Biotech

Inova’s Connect for Biotech helps out-licensing biotech and pharma companies increase their visibility, find new partners faster, and get valuable strategic insights. Over 2000 biopharma companies including 90% of the Top 50 pharma companies already use this online platform to showcase their assets, engage in conversations with potential partners, and receive valuable feedback from in-licensors. ​ 

In this webinar, Rajika Perera, Co-Founder and CEO of Poseidon LLC, shares his first-hand experience and front-line success using the Connect for Biotech platform. He explains how the platform helped Poseidon gain visibility for the asset they listed, and why he quickly added additional assets to Poseidon’s online portfolio. Inova Global Chief Product Officer Robin Knight will join the webinar to present the Connect for Biotech platform, explain its core capabilities for biotechs and pharma companies, and reveal why it’s the perfect companion to outreach efforts at partnering conferences like BIO Europe.

Watch this replay to get expert insights from our panelists:
Raj-Poseidon
Rajika Perera
Co-Founder and Chief Executive Officer
Poseidon LLC
robin-knight
Robin Knight
Global Chief Product Officer
Inova

Please complete the form below

All fields marked with a * are required.
By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

Resources you may be interested in

Opportunities-Kanban-board

Inova for Biotech

Read use case
gene_therapy

The Biotech Journey: From Inception to Exit

Watch webinar replay
partnering2030

Partnering 2030: The Biotech Perspective

Get the report

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.